KaydedilenlerDerginizi ekleyin

Dergiler / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 1

Is there a Difference between Typical and Atypical Hippocampal Sclerosis Regarding Pre-Operative Blood Inflammatory Markers?

Oğuz BARAN
Seher Naz YENİ
Rahşan KEMERDERE
Taner TANRIVERDİ
Mehmet Yiğit AKGÜN
Süreyya TOKLU
Orkhan ALIZADA
Sayfa
87–92
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Discussion and Conclusion: Although no differences between typical and atypical HS were demonstrated, there was a trend to increase in the levels of some inflammatory markers in typical HS which is severe form of neuronal loss compared to atypical HS and further studies with larger cohort of retrospective and preferably prospective are needed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: The purpose of this retrospective study was to provide whether there was a difference regarding pre-operative inflammatory markers between typical and atypical hippocampal sclerosis (HS).
📊
Temel Bulgular & Veri:Methods: For this purpose, 44 patients who underwent epilepsy surgery due to drug-resistant temporal lobe epilepsy were included.
💡
Sonuç & Katkı:Discussion and Conclusion: Although no differences between typical and atypical HS were demonstrated, there was a trend to increase in the levels of some inflammatory markers in typical HS which is severe form of neuronal loss compared to atypical HS and further studies with larger cohort of retrospective and preferably prospective are needed.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: The purpose of this retrospective study was to provide whether there was a difference regarding pre-operative inflammatory markers between typical and atypical hippocampal sclerosis (HS). Methods: For this purpose, 44 patients who underwent epilepsy surgery due to drug-resistant temporal lobe epilepsy were included. Pre-operative neutrophil, lymphocyte, monocyte, and platelet counts as well as neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio, and systemic immune-inflammation index) were noted from peripheral blood tests. Results: Although the majority of inflammatory markers showed higher levels in typical HS, no significant differences were found. None of the markers studied showed a correlation with the degree of neuronal loss. Discussion and Conclusion: Although no differences between typical and atypical HS were demonstrated, there was a trend to increase in the levels of some inflammatory markers in typical HS which is severe form of neuronal loss compared to atypical HS and further studies with larger cohort of retrospective and preferably prospective are needed.

🔖

Bu Makaleye Atıf Yap

BARAN, O., YENİ, S. N., KEMERDERE, R., TANRIVERDİ, T., AKGÜN, M. Y., TOKLU, S., ALIZADA, O. (2022). Is there a Difference between Typical and Atypical Hippocampal Sclerosis Regarding Pre-Operative Blood Inflammatory Markers?. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 1, 87–92. https://ajindex.com/articles/535863

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Tanriverdi T, Olivier A, Poulin N, Andermann F, Dubeau F. Longterm seizure outcome after mesial temporal lobe epilepsy surgery: Corticalamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg 2008;108:517– 24
  2. Kemerdere R, Ahmedov ML, Alizada O, Yeni SN, Oz B, Tanriverdi T. Effect of temporal neocortical pathology on seizure freeness in adult patients with temporal lobe epilepsy. World Neurosurg 2018;116:e801–5
  3. Tanriverdi T, Poulin N, Olivier A. Life 12 years after temporal lobe epilepsy surgery: A long-term, prospective clinical study. Seizure 2008;17:339–49
  4. Thom M, Eriksson S, Martinian L, Caboclo LO, McEvoy AW, Duncan JS, et al. Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: Neuropathological features. J Neuropathol Exp Neurol 2009;68:928–38
  5. Silverberg J, Ginsburg D, Orman R, Amassian V, Durkin HG, Stewart M. Lymphocyte infiltration of neocortex and hippocampus after a single brief seizure in mice. Brain Behav Immun 2010;24:263–72
  6. Gales JM, Prayson RA. Chronic inflammation in refractory hippocampal sclerosis-related temporal lobe epilepsy. Ann Diagn Pathol 2017;30:12–6
  7. Ahmedov ML, Kemerdere R, Baran O, Inal BB, Gumus A, Coskun C, et al. Tissue expressions of soluble human epoxide hydrolase-2 enzyme in patients with temporal lobe epilepsy. World Neurosurg 2017;106:46–50
  8. Varvel NH, Neher JJ, Bosch A, Wang W, Ransohoff RM, Miller RJ, et al. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus. Proc Natl Acad Sci USA 2016;113:E5665–74
  9. Leal B, Chaves J, Carvalho C, Rangel R, Santos A, Bettencourt A, et al. Brain expression of inflammatory mediators in mesial temporal lobe epilepsy patients. J Neuroimmunol 2017;313:82–8
  10. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7:31–40
  11. Rana A, Musto AE. The role of inflammation in the development of epilepsy. J Neuroinflammation 2018;15:144
  12. Zattoni M, Mura ML, Deprez F, Schwendener RA, Engelhardt B, Frei K, et al. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci 2011;31:4037–50
  13. Zadora P, Dabrowski W, Czarko K, Smolen A, Kotlinska-Hasiec E, Wiorkowski K, et al. Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor - a pilot study. Neurol Neurochir Pol 2015;49:41–4
  14. Zheng SH, Huang JL, Chen M, Wang BL, Ou QS, Hu